The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final clinical results of a randomized phase II international trial of everolimus vs. sunitinib in patients with metastatic non-clear cell renal cell carcinoma (ASPEN).
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Samuel Broderick
No Relationships to Disclose
 
Tim Eisen
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Honoraria - Astellas Pharma; AVEO; GlaxoSmithKline; Pfizer
Consulting or Advisory Role - Astellas Pharma; AVEO; GlaxoSmithKline; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Walter Michael Stadler
Honoraria - Bayer; CVS Caremark; Dendreon; Johnson & Johnson; medpacto; Merck; Millennium; Novartis; Roche/Genentech; Veridex
Consulting or Advisory Role - Bayer; CVS Caremark; Dendreon; Genentech/Roche; Medivation; medpacto; Millennium; Novartis; Sotio; Veridex
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly/ImClone (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Other Relationship - UpToDate
 
Robert J. Jones
Honoraria - GlaxoSmithKline; Pfizer
Consulting or Advisory Role - GlaxoSmithKline; Pfizer
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Novartis
 
Jorge A. Garcia
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Pfizer
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis
 
Joel Picus
No Relationships to Disclose
 
Robert E. Hawkins
No Relationships to Disclose
 
John D. Hainsworth
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Johnson & Johnson (Inst); Lilly (Inst); Novartis (Inst)
 
Christian K. Kollmannsberger
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer; Sanofi
 
Theodore F. Logan
Consulting or Advisory Role - Argos Therapeutics; AVEO; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Novartis; Pfizer; Prometheus; Wyeth
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer; Prometheus; Wyeth
Research Funding - Abbott Laboratories (Inst); Abraxis BioScience (Inst); Acceleron Pharma (Inst); Amgen (Inst); Argos Therapeutics (Inst); AstraZeneca (Inst); AVEO (Inst); BioVex (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); GlaxoSmithKline (Inst); immatics (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Roche (Inst); Roche (Inst); Synta (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Igor Puzanov
No Relationships to Disclose
 
Lisa M. Pickering
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Sanofi
 
Christopher W. Ryan
Consulting or Advisory Role - EMD Serono; Genentech; Janssen Oncology; Onyx; Pfizer
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - Millennium
 
Andrew Protheroe
No Relationships to Disclose
 
Christine M. Lusk
No Relationships to Disclose
 
Sadie Oberg
No Relationships to Disclose
 
Susan Halabi
Consulting or Advisory Role - Bayer; Oncogenex; Sanofi
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - bayer
 
Daniel J. George
Honoraria - Algeta ASA; Amgen; Astellas Pharma; AVEO; Dendreon; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Algeta ASA; Astellas Pharma; Aveo; Bayer; BIND Biosciences; Dendreon; Exelixis; GlaxoSmithKline; Medivation; Novartis; Pfizer; progenics; Sanofi; Viamet Pharmaceuticals
Speakers' Bureau - Dendreon; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Progenics (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Algeta/Bayer; Astellas Pharma; AVEO; Bristol-Myers Squibb; Dendreon; Pfizer; Progenics; Sanofi